408 related articles for article (PubMed ID: 32038101)
21. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
Kothari M; Rathod V
Indian J Ophthalmol; 2017 Nov; 65(11):1178-1181. PubMed ID: 29133646
[TBL] [Abstract][Full Text] [Related]
22. Effect of Low-Concentration Atropine Eye Drops in Controlling the Progression of Myopia in Children: A One- and Two-Year Follow-Up Study.
Zhang H; Yang P; Li Y; Zhang W; Li S
Ophthalmic Epidemiol; 2024 Jun; 31(3):240-248. PubMed ID: 37528608
[TBL] [Abstract][Full Text] [Related]
23. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
[TBL] [Abstract][Full Text] [Related]
25. Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.
Pérez-Flores I; Macías-Murelaga B; ; Barrio-Barrio J
Sci Rep; 2023 Sep; 13(1):16310. PubMed ID: 37770602
[TBL] [Abstract][Full Text] [Related]
26. Will the long-term use of atropine eye drops in children increase the risk of dry eye?
Zhao F; Ma JX
Med Hypotheses; 2019 Nov; 132():109331. PubMed ID: 31421421
[TBL] [Abstract][Full Text] [Related]
27. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
[TBL] [Abstract][Full Text] [Related]
28. Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study.
Lee CY; Sun CC; Lin YF; Lin KK
BMC Ophthalmol; 2016 Jul; 16():114. PubMed ID: 27435576
[TBL] [Abstract][Full Text] [Related]
29. Atropine for the treatment of childhood myopia.
Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Nakamura Y; Sotozono C; Oshika T; Morimoto T; Nishida K; Nishikawa N; Song YS; Tokutake T; Nishi Y; Shigeno Y; Kurihara T; Negishi K; Tsubota K; Ono M; Nakai T; Tan D; Tanaka S; Kinoshita S;
Jpn J Ophthalmol; 2021 May; 65(3):315-325. PubMed ID: 33586090
[TBL] [Abstract][Full Text] [Related]
31. Effects of 0.05% racanisodamine on pupil size and accommodation.
Chen Z; Li T; Yao P; Xu Y; Zhou X
Optom Vis Sci; 2010 Dec; 87(12):966-70. PubMed ID: 20935583
[TBL] [Abstract][Full Text] [Related]
32. [Atropine for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines].
Schittkowski MP; Sturm V
Klin Monbl Augenheilkd; 2018 Apr; 235(4):385-391. PubMed ID: 29270929
[TBL] [Abstract][Full Text] [Related]
33. Low-Concentration Atropine Eye Drops for Myopia Progression.
Li FF; Yam JC
Asia Pac J Ophthalmol (Phila); 2019; 8(5):360-365. PubMed ID: 31478936
[TBL] [Abstract][Full Text] [Related]
34. Effect of Atropine 0.01% Eye Drops on the Difference in Refraction and Axial Length between Right and Left Eyes.
Liang X; Wei S; Li SM; An W; Du J; Sun Y; Gan J; Bai W; Cai Z; Song Q; Yin L; Wang N
Ophthalmic Res; 2023; 66(1):496-505. PubMed ID: 36603556
[TBL] [Abstract][Full Text] [Related]
35. Assessment of myopic rebound effect after discontinuation of treatment with 0.01% atropine eye drops in Japanese school-age children.
Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Tanaka S; Kinoshita S;
Jpn J Ophthalmol; 2023 Sep; 67(5):602-611. PubMed ID: 37548816
[TBL] [Abstract][Full Text] [Related]
36. [Combination with different anticholinergic eyedrops for the treatment of children myopia].
Han WT; Rong A; Xu W
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1859-1863. PubMed ID: 31269580
[No Abstract] [Full Text] [Related]
37. Risk factors for rapid axial length elongation with low concentration atropine for myopia control.
Fu A; Stapleton F; Wei L; Wang W; Zhao B; Watt K; Yu S; Cui C; Lyu Y
Sci Rep; 2021 Jun; 11(1):11729. PubMed ID: 34083576
[TBL] [Abstract][Full Text] [Related]
38. Effects of different concentrations of atropine on controlling myopia in myopic children.
Shih YF; Chen CH; Chou AC; Ho TC; Lin LL; Hung PT
J Ocul Pharmacol Ther; 1999 Feb; 15(1):85-90. PubMed ID: 10048351
[TBL] [Abstract][Full Text] [Related]
39. [Side Effects of Low Dose Atropine].
Nishiyama Y; Moriyama M; Fukamachi M; Uchida A; Miyaushiro H; Kurata A; Tokoro T; Ohno-Matsui K
Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):812-6. PubMed ID: 26685486
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis.
Ha A; Kim SJ; Shim SR; Kim YK; Jung JH
Ophthalmology; 2022 Mar; 129(3):322-333. PubMed ID: 34688698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
